LCM
Laurion Capital Management Portfolio holdings
AUM
$867M
1-Year Return
5.19%
This Quarter Return
-4.61%
1 Year Return
+5.19%
3 Year Return
+14.26%
5 Year Return
+18.43%
10 Year Return
+26.97%
AUM
$2.39B
AUM Growth
-$1.8B
(-43%)
Cap. Flow
-$1.48B
Cap. Flow
% of AUM
-61.99%
Top 10 Holdings %
Top 10 Hldgs %
56.42%
Holding
596
New
187
Increased
52
Reduced
54
Closed
244
Top Buys
| 1 |
Warner Bros
WBD
|
$213M |
| 2 |
Lowe's Companies
LOW
|
$62.8M |
| 3 |
Morgan Stanley
MS
|
$47M |
| 4 |
Citigroup
C
|
$46M |
| 5 |
CLR
CONTINENTAL RESOURCES INC.
CLR
|
$43M |
Top Sells
| 1 |
DISCA
Discovery, Inc. Series A Common Stock
DISCA
|
$338M |
| 2 |
International Flavors & Fragrances
IFF
|
$284M |
| 3 |
Alibaba
BABA
|
$167M |
| 4 |
T-Mobile US
TMUS
|
$166M |
| 5 |
Micron Technology
MU
|
$149M |
Sector Composition
| 1 | Healthcare | 31.34% |
| 2 | Communication Services | 18.76% |
| 3 | Consumer Discretionary | 15.12% |
| 4 | Utilities | 9.34% |
| 5 | Financials | 7.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
PayPal
PYPL
$65.4B
| $4.11M | 0.06% |
+58,797
| New | +$4.11M |
|
77
Dow Inc
DOW
$16.9B
| $3.97M | 0.06% |
+76,896
| New | +$3.97M |
|
78
lululemon athletica
LULU
$24.7B
| $3.94M | 0.06% |
14,467
| – | – |
|
|
MBAC.U
79
DELISTED
M3-Brigade Acquisition II Corp. Units, each consisting of one share of Class A common stock, and one-third of one redeemable warrant
MBAC.U
| $3.92M | 0.06% |
400,000
| – | – |
|
80
Oracle
ORCL
$626B
| $3.91M | 0.06% |
+56,003
| New | +$3.91M |
|
81
Aldeyra Therapeutics
ALDX
$332M
| $3.88M | 0.06% |
+971,781
| New | +$3.88M |
|
82
Lineage Cell Therapeutics
LCTX
$274M
| $3.83M | 0.06% |
+2,422,367
| New | +$3.83M |
|
83
Viking Therapeutics
VKTX
$2.98B
| $3.83M | 0.06% |
+1,323,809
| New | +$3.83M |
|
84
Pliant Therapeutics
PLRX
$100M
| $3.77M | 0.06% |
+470,601
| New | +$3.77M |
|
85
Ross Stores
ROST
$50B
| $3.68M | 0.06% |
+52,405
| New | +$3.68M |
|
86
Entegris
ENTG
$12.1B
| $3.24M | 0.05% |
35,142
+27,814
| +380% | +$2.56M |
|
87
GH Research
GHRS
$872M
| $3.14M | 0.05% |
314,930
| – | – |
|
88
UroGen Pharma
URGN
$870M
| $3.12M | 0.05% |
+380,600
| New | +$3.12M |
|
89
Scholar Rock
SRRK
$3.12B
| $3.09M | 0.05% |
+562,182
| New | +$3.09M |
|
90
Rallybio
RLYB
$24.5M
| $3.04M | 0.05% |
402,000
+2,000
| +0.5% | +$15.1K |
|
91
Arrowhead Research
ARWR
$3.87B
| $3M | 0.05% |
+85,128
| New | +$3M |
|
92
Tractor Supply
TSCO
$32.1B
| $2.97M | 0.05% |
+76,680
| New | +$2.97M |
|
93
Wells Fargo
WFC
$262B
| $2.89M | 0.04% |
73,696
-148,904
| -67% | -$5.83M |
|
94
Wave Life Sciences
WVE
$1.3B
| $2.83M | 0.04% |
+871,500
| New | +$2.83M |
|
95
Meta Platforms (Facebook)
META
$1.88T
| $2.79M | 0.04% |
17,316
+16,916
| +4,229% | +$2.73M |
|
96
Zimmer Biomet
ZBH
$20.8B
| $2.78M | 0.04% |
+26,499
| New | +$2.78M |
|
|
VIRX
97
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $2.71M | 0.04% |
+698,000
| New | +$2.71M |
|
98
Zevra Therapeutics
ZVRA
$501M
| $2.6M | 0.04% |
+582,261
| New | +$2.6M |
|
99
Yum China
YUMC
$16.4B
| $2.59M | 0.04% |
+53,382
| New | +$2.59M |
|
|
VMW
100
DELISTED
VMware, Inc
VMW
| $2.46M | 0.04% |
21,587
-18,068
| -46% | -$2.06M |
|